KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $6.02 $13.63 Friday, 26th Apr 2024 VERV stock ended at $6.16. This is 0.96% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.47% from a day low at $6.02 to a day high of $6.41.
90 days $6.02 $19.34
52 weeks $6.02 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
Jun 05, 2023 $16.14 $17.14 $16.14 $16.74 534 303
Jun 02, 2023 $15.76 $16.31 $15.42 $16.27 620 407
Jun 01, 2023 $15.44 $15.71 $15.11 $15.41 319 162
May 31, 2023 $15.35 $16.59 $15.21 $15.48 628 494
May 30, 2023 $16.07 $16.49 $15.14 $15.33 446 023
May 26, 2023 $15.86 $16.14 $15.58 $15.99 397 213
May 25, 2023 $16.35 $16.82 $15.57 $15.87 733 735
May 24, 2023 $16.54 $16.74 $16.01 $16.41 478 087
May 23, 2023 $16.80 $17.48 $16.52 $16.71 543 050
May 22, 2023 $16.76 $17.20 $16.75 $16.82 486 458
May 19, 2023 $16.61 $16.99 $16.16 $16.74 591 386
May 18, 2023 $16.84 $17.05 $15.75 $16.34 452 334
May 17, 2023 $16.69 $17.19 $16.38 $17.14 791 471
May 16, 2023 $17.30 $17.55 $15.94 $16.62 537 238
May 15, 2023 $17.98 $18.64 $17.30 $17.66 513 900
May 12, 2023 $18.14 $18.14 $17.26 $17.53 466 918
May 11, 2023 $18.29 $18.66 $17.42 $18.15 852 314
May 10, 2023 $18.00 $19.28 $17.99 $18.41 671 086
May 09, 2023 $15.68 $17.92 $15.60 $17.75 758 075
May 08, 2023 $16.40 $16.94 $15.48 $16.21 445 024
May 05, 2023 $16.57 $16.93 $16.21 $16.24 331 204
May 04, 2023 $16.02 $16.54 $15.72 $16.31 428 904
May 03, 2023 $15.46 $16.81 $15.39 $16.15 849 791
May 02, 2023 $16.07 $16.14 $15.06 $15.25 669 528
May 01, 2023 $15.90 $16.31 $15.59 $16.04 447 174
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT